Abstract
We present a compartmental, age-stratified, nation-level, extended SEIQRD model to model SARS-CoV-2 spread in Belgium. We demonstrate the robustness of the calibration procedure by calibrating the model using incrementally larger datasets and dissect the model results by computing the effective reproduction number at home, in workplaces, in schools and during leisure activities. We find that schools are a major contributor to SARS-CoV-2 spread, with the potential to increase the basic reproduction number from Re = 0.66 ± 0.04 to Re = 1.09 ± 0.05 under lockdown measures. The model accounts for the main characteristics of SARS-CoV-2 transmission and COVID-19 disease and features a detailed representation of hospitals with parameters derived from two Ghent (Belgium) hospitals. Social contact during the pandemic is modelled by scaling pre-pandemic contact matrices with publically available mobility data from Google and with effectivity parameters inferred from hospitalization data. The combination of the deterministic epidemiological model, which incorporates rigid a-priori knowledge on disease dynamics, and the calibrated effectivity parameters in the social contact model allow us to combine the ease of long-term extrapolation and scenario-analysis of compartmental models with the flexibility of a data-driven model.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Ghent University Special Research Fund. The funding source played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This version was revised to incorporate all work done between first submission on July 21st, 2020 and March 29th, 2021 and to incorporate the comments after a peer review by the journal Epidemics.
↵3 Largest absolute eigenvalue.
Data Availability
All code and data is publically available on the BIOMATH GitHub repo (https://github.com/UGentBiomath/COVID19-Model/).
